Polyclonal Rabbit anti‑Human ADGRF2 / GPR111 Antibody (aa366‑393, IHC, WB) LS‑C321711
Polyclonal Rabbit anti‑Human ADGRF2 / GPR111 Antibody (aa366‑393, IHC, WB) LS‑C321711
Antibody:
ADGRF2 / GPR111 Rabbit anti-Human Polyclonal (aa366-393) Antibody
Application:
IHC, WB, ELISA
Format:
Unconjugated, Unmodified
Overview
Antibody:
ADGRF2 / GPR111 Rabbit anti-Human Polyclonal (aa366-393) Antibody
Application:
IHC, WB, ELISA
Format:
Unconjugated, Unmodified
Specifications
Description
GPR111 antibody LS-C321711 is an unconjugated rabbit polyclonal antibody to human GPR111 (ADGRF2) (aa366-393). Validated for ELISA, IHC and WB.
Target
Human ADGRF2 / GPR111
Synonyms
ADGRF2 | G protein-coupled receptor 111 | GPR111 | PGR20 | HGPCR35
Reactivity
Human
(tested or 100% immunogen sequence identity)
Conjugations
Unconjugated.
Also available conjugated with
APC,
Biotin,
FITC,
PE,
HRP.
Purification
Affinity purified
Modifications
Unmodified.
Also available
Azide-free.
Specificity
This GP111 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 366-393 amino acids from the Central region of human GP111.
Applications
- IHC (1:10 - 1:50)
- Western blot (1:100 - 1:500)
- ELISA (1:1000)
|
Performing IHC? See our complete line of Immunohistochemistry Reagents including antigen retrieval solutions, blocking agents
ABC Detection Kits and polymers, biotinylated secondary antibodies, substrates and more.
|
Presentation
PBS, pH 7.2, 0.09% Sodium Azide
Storage
Short term: store at 4°C. Long term: aliquot and store at -20°C. Avoid freeze-thaw cycles.
Restrictions
For research use only. Intended for use by laboratory professionals.
Guarantee
This antibody carries the LSBio 100% Guarantee.
LSBio Guarantee
Featured Products
Species:
Human
Applications:
IHC, Western blot, ELISA
Species:
Human
Applications:
Western blot, ELISA
Source:
E. coli
Tag:
His-GST
Request SDS/MSDS
To request an SDS/MSDS form for this product, please contact our Technical Support department at:
Technical.Support@LSBio.com
Requested From: United States
Date Requested: 11/23/2024